Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

125
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
125
Pharmacovigilance01:19

Pharmacovigilance

901
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
901
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

50
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
50

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Symptoms and subtypes of patients with lower urinary tract dysfunction - insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network.

Nature reviews. Urology·2026
Same author

DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1/2-Dependent Tumorigenic Signaling in Prostate Cancer.

Cancer research communications·2026
Same author

Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications.

The Prostate·2026
Same author

Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank.

Circulation. Genomic and precision medicine·2026
Same author

An intra-patient contemporaneous comparison of <sup>18</sup>F-piflufolastat and <sup>18</sup>F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
Same journal

Artificial Intelligence in Urologic Documentation: A Review of Emerging Capabilities and the Ongoing Need for Human Oversight.

Current urology reports·2026
查看所有相关文章

相关实验视频

Updated: Jul 23, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

主动监控是否过于积极?

James T Kearns1, Brian T Helfand2

  • 1Division of Urology, NorthShore University HealthSystem, 2180 Pfingsten Rd., Suite 3000, Glenview, Evanston, IL, 60026, USA. jkearns@northshore.org.

Current urology reports
|July 12, 2023
PubMed
概括
此摘要是机器生成的。

目前的前列腺癌积极监测协议可能涉及过度测试. 虽然MRI和生物标志物有助于风险分层,但定期活检仍然对安全至关重要,因为遗漏它们尚未被证明是可行的.

关键词:
积极监视活动的监视活动.生物标志物 生物标志物前列腺核磁共振成像前列腺癌是什么意思 前列腺癌是什么意思

更多相关视频

Visualizing Efficacy of Pesticides Against Disease Vector Mosquitoes in the Field
10:49

Visualizing Efficacy of Pesticides Against Disease Vector Mosquitoes in the Field

Published on: March 16, 2019

8.6K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K

相关实验视频

Last Updated: Jul 23, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Visualizing Efficacy of Pesticides Against Disease Vector Mosquitoes in the Field
10:49

Visualizing Efficacy of Pesticides Against Disease Vector Mosquitoes in the Field

Published on: March 16, 2019

8.6K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K

科学领域:

  • 在瘤学瘤学.
  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 积极监测是管理低风险前列腺癌的常见策略.
  • 协议通常包括频繁的监测,如PSA测试,诊所访问,MRI和活检.

研究的目的:

  • 评估目前的前列腺癌活跃监测协议是否导致过度测试.
  • 评估串行监控组件的必要性和实用性.

主要方法:

  • 对多参数MRI,血清生物标志物和连续前列腺活检的最新研究进行审查.
  • 分析这些工具在主动监控中的预测价值.

主要成果:

  • 多参数MRI和血清生物标志物显示出风险分层的前景.
  • 没有证据支持在积极监测中安全地省略定期前列腺活检.
  • 额外的MRI或生物标志物并不能持续改善更高程度疾病的预测.

结论:

  • 目前的积极监测协议可能对一些患者来说过于密集.
  • 定期的前列腺活检仍然是积极监测安全的关键组成部分.
  • 需要进一步的研究,以优化监测策略,而不会影响患者的安全.